teduglutide biosimilar (PJ009)
/ PEG-BIO Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 26, 2024
A Study of PJ009 in Healthy Adult Volunteers
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd.
New P1 trial • Gastrointestinal Disorder • Short Bowel Syndrome
July 22, 2024
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
(clinicaltrials.gov)
- P3 | N=72 | Recruiting | Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd.
New P3 trial • Gastrointestinal Disorder • Short Bowel Syndrome
1 to 2
Of
2
Go to page
1